ISSN : 2146-3123
E-ISSN : 2146-3131

Impact Factor
Slider 1
Slider 3
Slider 4
Slider 5
Slider 6

News See All

Following its historic entry into the Q2 quartile in 2022, Balkan Medical Journal has now achieved Q1 ranking in 2024, making it the first Turkish medical journal to reach this top-tier distinction. With a notable Impact Factor of 3.8, this elevation underscores the journal’s commitment to excellence and its growing global influence in the field of medical research
We are pleased to announce that, according to the 2024 Scopus data, Balkan Medical Journal has achieved a CiteScore of 3.7. This reflects the journal’s continued commitment to publishing high-quality, impactful research in the field of general medicine.  
We are pleased to report that our journal has achieved an Impact Factor of 1.9 for the year 2023.  
Balkan Medical Journal adopts the WAME recommendations on ChatGPT and Chatbots related to scientific publications http://www.balkanmedicaljournal.org/static.php?id=10  
In the field of computer science, known as artificial intelligence, algorithms imitate reasoning tasks that are typically performed by humans. The techniques that allow machines to learn and get better at tasks such as recognition and prediction, which form the basis of clinical practice, are referred to as machine learning, which is a subfield of artificial intelligence. http://balkanmedicaljournal.org/uploads/pdf/pdf_BMJ_2461.pdf
Type 1 interferonopathy is a novel context reflecting a group of inborn disorders sharing common pathway disturbances. This group of diseases is characterized by autoimmunity and autoinflammation caused by an upregulation of type 1 interferons (IFN)s due to certain genetic mutations. http://balkanmedicaljournal.org/uploads/pdf/pdf_BMJ_2501.pdf

Articles See All

Ahmed S. Doghish, Reda M. Mansour, Sherif S. Abdel Mageed, et al.
In this review, Doghish et al aim to clarify the therapeutic potential of microRNAs in addressing the interrelation between obesity and cancer.
Yanrong Zhu, Kui Fan, Xujuan Zhao, et al.
In their study, Zhu et al. aim to determine if elevated serum Pentraxin-3 levels at admission are indicative of poor functional prognosis in patients with acute ischemic stroke
Yichuan Liu, Zongquan Wen, Nanrui Zeng
Weekend catch-up sleep (≥1 hour) may worsen the link with hepatic steatosis and atherosclerotic cardiovascular disease risk, according to Liu et al., suggesting that it may play a moderating role in cardiovascular preventative measures.
Wenzheng Han, Jinrong Lv, Mintuo Wang, et al.
This original article by Han et al. discusses how exo-CD155 is associated with the development of HCC and immune suppression, offering a potential early diagnostic marker and therapeutic target beyond conventional surface checkpoints.
Serkan Gönültaş, Numan Baydilli, Mehmet Solakhan, et al.
Gönültaş et al. report that hematospermia is predominantly caused by benign, self-limiting conditions, emphasizing the importance of targeted imaging only in high-risk patients to avoid unnecessary interventions.

Image Corner

News from Balkan Medical Journal See All

The Balkan Medical Journal has published a groundbreaking consensus report on Takotsubo Syndrome (TTS), developed with the collaboration of experts from 16 countries. This report addresses the pressing diagnostic and treatment challenges associated with TTS, a condition characterized by reversible heart dysfunction that often mimics myocardial infarction. By providing actionable recommendations, the report aims to enhance diagnostic accuracy and improve management strategies, fostering a more standardized approach to TTS care across global clinical settings. This international effort marks a significant step forward in addressing the complexities of TTS in medical practice.
The publisher of our journal has been changed. As of January 2022, Balkan Medical Journal started working with GALENOS. We will continue to use the same online manuscript tracking system (Manuscript Manager). However, there have been some changes to our website. We wanted to inform all our authors, readers, and reviewers.